PAPER Zaręba-Kozioł M, Szwajda A, Dadlez M, Wysłouch-Cieszyńska A, Lalowski M
SEARCH RESULTS
331171 RESULTS
PAPER Tucsek Z, Toth P, Tarantini S, Sosnowska D, Gautam T, Warrington JP, Giles CB, Wren JD, Koller A, Ballabh P, Sonntag WE, Ungvari Z, Csiszar A
Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice.
J Gerontol A Biol Sci Med Sci. 2014 Nov;69(11):1339-52. Epub 2014 Jun 3 PubMed: 24895269PAPER Boyd RE, Valenzano KJ
Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases.
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3001-5. Epub 2014 May 14 PubMed: 24894562PAPER Lemos R, Simões MR, Santiago B, Santana I
The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.
J Neuropsychol. 2014 Jun 3; PubMed: 24894485PAPER Wu H, Williams J, Nathans J
Complete morphologies of basal forebrain cholinergic neurons in the mouse.
Elife. 2014 May 7;3:e02444. PubMed: 24894464PAPER Lim WL, Martins IJ, Martins RN
The involvement of lipids in Alzheimer's disease.
J Genet Genomics. 2014 May 20;41(5):261-74. Epub 2014 May 2 PubMed: 24894353PAPER Mauri M, Sinforiani E, Cuzzoni MG, Bono G, Zucchella C
Driving habits in patients with dementia: a report from Alzheimer's disease assessment units in northern Italy.
Funct Neurol. 2014 Jun 6;:1-6. PubMed: 24894335PAPER Avachat AM, Oswal YM, Gujar KN, Shah RD
Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles.
Curr Drug Deliv. 2014;11(3):359-70. PubMed: 24893995PAPER Peng Y, Hu Y, Xu S, Rong X, Li J, Li P, Wang L, Yang J, Wang X
Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
J Pharmacol Exp Ther. 2014 Aug;350(2):361-74. Epub 2014 Jun 3 PubMed: 24893984PAPER Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M, Holtzman DM
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.
Mol Neurodegener. 2014 Jun 3;9:20. PubMed: 24893973PAPER Henderson VW
Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.
Climacteric. 2014 Dec;17 Suppl 2:38-46. Epub 2014 Aug 17 PubMed: 24893836PAPER Wang DM, Li SQ, Wu WL, Zhu XY, Wang Y, Yuan HY
Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer's disease.
Neurochem Res. 2014 Aug;39(8):1533-43. Epub 2014 Jun 4 PubMed: 24893798PAPER d'Orsi G, Specchio LM, Apulian Study Group on Senile Myoclonic Epilepsy
Progressive myoclonus epilepsy in Down syndrome patients with dementia.
J Neurol. 2014 Aug;261(8):1584-97. Epub 2014 Jun 4 PubMed: 24893590PAPER Winter Holz A, Nunes BP, Thume E, Lange C, Facchini LA
Prevalence of cognitive impairment and associated factors among the elderly in Bage, Rio Grande do Sul, Brazil.
Rev Bras Epidemiol. 2013 Dec;16(4):880-8. PubMed: 24896593PAPER Tomita T, Sugawara N, Kaneda A, Okubo N, Iwane K, Takahashi I, Kaneko S, Yasui-Furukori N
Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptoms.
Psychiatry Clin Neurosci. 2014 Mar;68(3):176-81. PubMed: 24895733Current Filters
No filters selected